MENU
ARCT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Arcturus Therapeutics Holdings (ARCT) Earnings Date & Reports

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases... Show more

A.I. Advisor
published Earnings

ARCT is expected to report earnings to fall 423.42% to $3.59 per share on May 12

Arcturus Therapeutics Holdings ARCT Stock Earnings Reports
Q1'25
Est.
$3.59
Q4'24
Missed
by $0.92
Q3'24
Beat
by $0.31
Q2'24
Beat
by $0.38
Q1'24
Beat
by $0.06
The last earnings report on March 06 showed earnings per share of -111 cents, missing the estimate of -18 cents. With 362.42K shares outstanding, the current market capitalization sits at 257.23M.
View a ticker or compare two or three
ARCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of technology and therapeutics for rare diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
10628 Science Center Drive
Phone
+1 858 900-2660
Employees
180
Web
https://www.arcturusrx.com